Vanda Pharmaceuticals Gains Ownership Of The U.S. NDA And IND Applications For PONVORY From A Johnson & Johnson Company, Which Now Fully Allows Vanda To Commercialize PONVORY In The U.S.

Vanda Pharmaceuticals Inc. +3.49% Pre

Vanda Pharmaceuticals Inc.





0.00% Pre

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for PONVORY® (ponesimod) has been transferred to Vanda from a Johnson & Johnson Company, which now fully allows Vanda to commercialize PONVORY® in the U.S.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via